Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer

PURPOSE: Hormone receptor (HR)-positive, Human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) requires a therapeutic approach that takes into account multiple factors, with treatment being based on anti-estrogen hormone therapy (HT). As consensus documents are valu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Oncol
Main Authors: Alvarez-Lopez, I., Bezares, S., Dalmau Portulas, E., García-Martínez, E., García-Sáenz, J. Á., Gil-Gil, M., Martínez de Dueñas, E., Ribelles, N., Santaballa Bertrán, A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7316841/
https://ncbi.nlm.nih.gov/pubmed/32052382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-019-02269-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados